Print Page

Products found to contain undeclared medicines

The United Kingdom: Austrian authorities issue warning for Ramlostan Forte
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that the Austrian authorities have issued a warning for Ramlostan Forte manufactured by SC Parapharm, Romania. Ramlostan comes in white and blue packaging, with a picture of a ram at the top. Inside, there are ten blue capsules. The Austrian authority (AGES) has issued a warning for this product after finding it to contain tadalafil, a prescription-only medicine used in the treatment of erectile dysfunction and yohimbe, a medicinal herbal ingredient. Neither of these ingredients were declared on the packaging. Uncontrolled consumption of tadalafil is dangerous and could potentially cause serious adverse reactions such as heart attack, stroke and severe hypotension. Yohimbe can be toxic and cause panic attacks, high blood pressure, headache, nausea, paralysis, renal failure, seizure and death.

Please refer to the following website in MHRA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Wednesday, September 26, 2012
Issued at HKT 14:00